Peptide Supplier Guidance in California

Sourcing Peptides in California

California businesses looking to offer peptide therapies must navigate both federal FDA regulations and state-level compounding and prescribing rules. The peptide sourcing landscape in California includes access to licensed 503A compounding pharmacies, 503B outsourcing facilities, and FDA-approved branded products.

Key considerations for California businesses include ensuring your compounding pharmacy is properly licensed in California, verifying that bulk drug substances used are on the appropriate FDA category lists, and maintaining documentation that meets both federal and California state board requirements.

For medspas, clinics, and telehealth brands operating in California, we provide tailored supplier-match guidance that accounts for your specific business model, the regulatory environment in California, and the peptide therapies you plan to offer.